Expression of interest – Subject Matter Experts for eLearning, gastro, oesophageal, prostate cancers

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for experienced pharmacists to review the eLearning content for 3 modules:

  1. Gastro-intestinal cancer – 1 Subject matter expert
  2. Oesophageal cancer – 1 Subject matter expert
  3. Prostate cancer – 1 Subject matter expert

If you are currently working within these areas, have a minimum experience of 3 years in oncology, and would like to be part of this new project we would be delighted to have you apply as a reviewer.

To apply, please email [email protected] stating your current job title/role and place of work, and which module you wish to apply.

Additionally, we ask that you submit a brief statement (no more than 300 words) explaining why you are well suited for this role.

Please note, applications are only open to paid BOPA members, and will close on 1st of September 2025. We will let candidates know the outcome by 26th of September 2025.

The selected reviewer will be remunerated for their valuable time and dedication to this initiative. We understand the significance of your contributions and as a token of appreciation, the reviewer will be acknowledged on our website.

Thank you for considering this opportunity, and we appreciate your continued dedication to enhancing healthcare knowledge.

Best wishes,
BOPA eLearning Team

Latest News

By BOPA E&T Subcommittee on 18th November 2025

BOPA Introduction to Cancer Course, Scotland, March 2026 – registration OPENS soon!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article